Acalabrutinib Obinutuzumab Vs Obinutuzumab plus Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN
Jeff P. Sharman,Miklos Egyed,Wojciech Jurczak,Alan Skarbnik,Krish Patel,Ian W. Flinn,Manali Kamdar,Talha Munir,Renata Walewska, Marie Hughes,Laura Maria Fogliatto,Yair Herishanu,Versha Banerji,George Follows,Patricia A. Walker,Karin Karlsson,Paolo Ghia,Ann Janssens,Florence Cymbalista,John C. Byrd,Emmanuelle Ferrant,Alessandra Ferrajoli,William G. Wierda,Veerendra Munugalavadla, Catherine Wangui Wachira,Chuan-Chuan Wun,Jennifer A. Woyach BLOOD(2023)
AI 理解论文
溯源树
样例